Search results for "Opioids"
Oral drug for postpartum depression approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/10/oral-drug-for-postpartum-depression-approved.htm
1 Oct 2023
Limits on opioid prescribing didn't change overdoses, but did reduce adverse effects
A study of primary care patients analyzed the effects of a Vermont policy that limited the dose and duration of opioid prescriptions based on pain severity and required prescription drug monitoring program checks.
https://immattersacp.org/weekly/archives/2021/05/11/2.htm
11 May 2021
Big barrier to buprenorphine removed
The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
https://immattersacp.org/archives/2023/03/big-barrier-to-buprenorphine-removed.htm
1 Mar 2023
Naloxone coprescribing appears uncommon in patients taking long-term opioids
A retrospective cross-sectional study of U.S. retail pharmacy claims found that 2.3% of long-term opioid therapy episodes included naloxone coprescribing, despite recommendations supporting this practice.
https://immattersacp.org/weekly/archives/2021/02/23/5.htm
23 Feb 2021
Medical schools respond to the opioid epidemic
Until very recently, medical schools offered little or no training in addiction medicine.
https://immattersacp.org/archives/2017/01/opioids-medical-education.htm
1 Jan 2017
RSV vaccine approved; several actions on opioids
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/06/rsv-vaccine-approved-several-actions-on-opioids.htm
1 Jun 2023
Lack of coordination between health care systems associated with fatal opioid overdoses
Veterans who received opioid prescriptions from both inside and outside the Veterans Affairs health system had two to three times the risk for fatal overdose versus those who received prescriptions from only one source.
https://immattersacp.org/weekly/archives/2019/03/12/1.htm
12 Mar 2019
One-third of primary care physicians do not support medications for opioid use disorder
Fewer than a quarter of surveyed primary care physicians expressed interest in treating patients with opioid use disorder, and only 11.8% were interested in obtaining a waiver to prescribe buprenorphine.
https://immattersacp.org/weekly/archives/2020/04/21/2.htm
21 Apr 2020
Q&A: DEA requires addiction training for all prescribers
The Drug Enforcement Administration is requiring eight hours of training related to substance use disorder treatment, sending clinicians scurrying to their continuing education providers for help.
https://immattersacp.org/archives/2023/05/dea-requires-addiction-training-for-all-prescribers.htm
1 May 2023
Stopping opioid treatment linked to increased risk of death from overdose or suicide in veterans
The risk of death from overdose or suicide increased immediately after starting or stopping opioids and continued to rise the longer patients were treated with opioids.
https://immattersacp.org/weekly/archives/2020/03/17/2.htm
17 Mar 2020